Imaging of Trabeculectomy Blebs Using the Spectral Domain Optical Coherence Tomography
SDOCT-TE
Imaging of Blebs After Trabeculectomy With Mitomycin C 0,02% Using the Spectral Domain Optical Coherence Tomography
1 other identifier
observational
30
1 country
1
Brief Summary
The aim of this study is imaging of trabeculectomy blebs regarding structure and function with the spectral domain optical coherence tomography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
July 8, 2011
CompletedFirst Posted
Study publicly available on registry
July 12, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedSeptember 10, 2013
September 1, 2013
9 months
July 8, 2011
September 9, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
grading of filtering bleb
December 2011
Study Arms (1)
Trabeculectomy
glaucoma patients undergoing trabeculectomy with mitomycin c 0,02%
Interventions
postoperative imaging of trabeculectomy blebs with the spectral domain optical coherence tomography
Eligibility Criteria
glaucoma patients who need a trabeculectomy with mitomycin C 0,02% for further reduction of intraocular pressure (IOP)
You may qualify if:
- glaucoma patients who need a trabeculectomy with mitomycin C 0,02% for further reduction of intraocular pressure, informed consent
You may not qualify if:
- patient without glaucoma, under 18 years of age, not willing to take part in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Eye Clinic Dresden
Dresden, Saxony, 01307, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karin R Hornykewycz, MD
University Eye Clinic Dresden, Fetscherstrasse 74, 01307 Dresden, Germany
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 8, 2011
First Posted
July 12, 2011
Study Start
March 1, 2011
Primary Completion
December 1, 2011
Study Completion
December 1, 2011
Last Updated
September 10, 2013
Record last verified: 2013-09